The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670250890) is a paclitaxel-coated percutaneous transluminal angioplasty balloon catheter with a 2.5 mm balloon diameter and 80 mm balloon length. Designed for peripheral vascular intervention, the Ranger DCB combines a low-dose drug coating with a refined balloon platform intended to support controlled drug transfer to the vessel wall during angioplasty.
Key Features
Paclitaxel drug coating with proprietary TransPax excipient technology for targeted drug transfer
Low nominal drug dose density designed to minimize particulate loss during tracking
Balloon diameter 2.5 mm and balloon working length 80 mm
Low-profile balloon platform engineered for trackability and crossability in tortuous peripheral anatomy
Compatible with 0.018 inch guidewire systems (confirm with current IFU)
Single-use, sterile, packaged for hospital and cath lab procurement
Clinical Applications
Percutaneous transluminal angioplasty of peripheral arteries as defined in the manufacturer Instructions for Use
Intended for use by trained interventional physicians in catheterization and hybrid suite environments
Procurement intended for hospitals, vascular centers, and ambulatory interventional facilities
Product Information
Brand: Boston Scientific
Product Line: Ranger Drug-Coated Balloon (DCB)
Category: Peripheral Balloon Catheters
REF/UPN: H74939670250890
Balloon Diameter: 2.5 mm
Balloon Length: 80 mm
Drug Coating: Paclitaxel with TransPax excipient
Catheter Working Length: Not specified in the located sources
Guidewire Compatibility: 0.018 inch (confirm with current IFU)
Sterility: Sterile, single use
Regulatory Status: Refer to current manufacturer documentation for region-specific clearances